OTCMKTS:SWRAY Swire Pacific Institutional Ownership Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Swire Pacific Limited Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $7.32 -0.20 (-2.66 %) (As of 02/26/2021 12:00 AM ET) Add Compare Share Today's Range$7.16Now: $7.32▼$7.3850-Day Range$5.94MA: $6.51▼$7.5252-Week Range$4.47Now: $7.32▼$9.20Volume12,415 shsAverage Volume28,768 shsMarket Capitalization$28.45 billionP/E Ratio2.92Dividend Yield2.19%Beta1.07 ProfileChartCompetitorsDividendInstitutional OwnershipHeadlinesShort Interest Institutional Ownership Institutional Ownership Changes (13F Filings) for Swire Pacific (OTCMKTS:SWRAY)Institutional Ownership Percentage: 0.11%Swire Pacific (OTCMKTS SWRAY) Institutional Buying and SellingReporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company12/31/2015EisnerAmper Wealth Management35,243$0.40M0.3%+16.6%0.000%(Data available from 1/1/2016 forward) This page was last updated on 2/26/2021 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here